Public medical research funding stimulates private R&D investment
Monthly Archives: February 2016
Can we kill cancer cells using new ‘smart drugs’
Cancer Research UK recently set out to find the current major challenges that need combatting in order to beat cancer. They presented seven challenges that would need to be overcome, and in this blog, originally posted on their website, they focus on the seventh: smart drugs.
1What makes research worth the effort? Inconsistencies between clinical trial protocols and the published results
Reports of inconsistencies between clinical trial protocols and the published results have focused mainly on commercial trials linked to pharmaceutical companies. Research published in Trials assessed this in academic trials and identified that these discrepancies in reporting are not only linked to clinical trials with commercial affiliations. Here, the authors discuss their research.
Podcast: Why we should all know more about sepsis
What is sepsis and why is sepsis awareness in the general public and healthcare staff critically important? In this podcast, we talk to Jean-Louis Vincent, Editor-in-Chief of Critical Care, about this and more. Listen to find out more!
Can we target cancer’s ‘super-controller’?
Cancer Research UK recently set out to find the current major challenges that need combatting in order to beat cancer. They presented seven challenges that would need to be overcome, and in this blog, originally posted on their website, they focus on the sixth: the super controller.
Unifying all of Europe in clinical trial participation: the ECRAN project
A recent publication in Trials details the development of the European Communication on Research Awareness Needs (ECRAN) project, which was designed to improve public knowledge about clinical trials across Europe. Here, Paola Mosconi answers questions on the project and how it aims to increase participation in clinical trials that cross European borders.
Access to clinical trial data from the European Medicines Agency
Today Trials publishes an article reporting a case series of 12 requests to the European Medicines Agency for regulatory data. The co-authors of the work explain more here.
New insights into the role of gender in breast cancer development
Breast Cancer Research recently published an article about the importance of studying male breast cancer in BRCA1 and BRCA2 mutation carriers. Here we asked Jonine Figueroa to explain more about the research.
2Does going ‘social’ help terminally-ill patients gain expanded access?
BMC Medicine recently published an article investigating whether the use of online petitions and social media actually helps patients gain access to experimental drugs. Co-author of the work, Timothy Mackey, explains more.
1Breast Cancer Research Image Competition Announcement 2016
We are happy to announce the launch of our new scientific breast cancer image competition, in partnership with the UK’s largest breast cancer charity, Breast Cancer Now and the leading breast cancer journal, Breast Cancer Research! Read on to find out how to enter…